|
|
Volumn 4, Issue 6, 2013, Pages 808-809
|
|
STAT5b in LGL leukemia - a novel therapeutic target?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCR ABL PROTEIN;
HYBRID PROTEIN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
JANUS KINASE;
METHOTREXATE;
MITOGEN ACTIVATED PROTEIN KINASE;
PIMOZIDE;
PREDNISONE;
PROTEIN KINASE;
STAT3 PROTEIN;
STAT5 PROTEIN;
STAT5B PROTEIN;
APOPTOSIS;
CELL SURVIVAL;
CYTOPENIA;
CYTOTOXIC T LYMPHOCYTE;
EDITORIAL;
GENE MUTATION;
GENE TARGETING;
HUMAN;
INFECTION SENSITIVITY;
LARGE GRANULAR LYMPHOCYTE LEUKEMIA;
MEMORY CELL;
NATURAL KILLER CELL;
NEUTROPENIA;
NK T CELL LYMPHOMA;
T CELL LYMPHOMA;
ANIMALS;
HUMANS;
LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC;
MICE;
MOLECULAR TARGETED THERAPY;
MUTATION;
SIGNAL TRANSDUCTION;
STAT5 TRANSCRIPTION FACTOR;
|
|
EID: 84880793935
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.1035 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|
